Nectar Lifesciences Board to consider final dividend

06 May 2013 Evaluate

Nectar Lifesciences has informed that a meeting of the Board of Directors of the Company will be held on May 15, 2013, to consider and approve the following: The Audited Financial Results for Financial Year 2012-13, Balance Sheet of the Company as at March 31, 2013 and Profit A Loss Accounts for the financial year ended on March 31, 2013 and matters related thereto, and recommendation of final dividend to the Members of the Company for Financial Year 2012-13.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

39.11 1.76 (4.71%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.